NEW YORK (GenomeWeb) – Cell detection and liquid biopsy firm RareCyte said today that it has raised $30 million in a private financing round, which it plans to use to advance commercial sales efforts and build new companion diagnostic partnerships.

The investment was led by 5AM Ventures with additional participation from existing investors including Telegraph Hill Partners.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Sponsored by

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.